Macro: Equity Derivatives 2008 First
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Macro: Equity Derivatives 2008 First

In first place for a second straight year is the nine-­member team piloted by Gabriela Baez, Evren Ergin, and Maneesh Deshpande. The group moved from Lehman Brothers to Barclays.


Gabriela Baez


Maneesh Deshpande


Evren Ergin

Gabriela Baez, Maneesh Deshpande, Evren Ergin & team Barclays


Phillip Mackintosh, Edward Tom & team Credit Suisse


John Marshall & team ­ Goldman Sachs


Heiko Ebens & team Merrill Lynch

In first place for a second straight year is the nine-­member team piloted by Gabriela Baez, 30, Evren Ergin, 37, and Maneesh Deshpande, 40. The group, which moved from Lehman Brothers following its acquisition last month by Barclays Capital’s parent, publishes “comprehensive reports that provide detailed anti­trust and regulatory analysis, and analysis of ­other aspects that affect two ­companies’ ability to complete a merger,” explains one buy-side enthusiast. Case in point: the team’s October 2007 analysis of Finnish mobile phone manufacturer Nokia Corp.’s bid to buy Navteq Corp., a Chicago-­based provider of digital maps, for $8.1 billion. ­Many analysts predicted that the deal would fail to win regulatory approval from the Euro­pean Union because of anti­trust concerns, and those concerns caused Navteq’s stock to trade well below the $78-per-share bid price. The team assured investors the deal would go through, and it did, closing in ­July. New co-­leader Phillip Mackintosh helps Edward Tom steer the Credit ­Suisse squad up one notch to second place. In June the team published “When Oil Hell Breaks Loose,” predicting that oil prices were about to plunge and advising investors to write short-­dated call options on oil exploration and production stocks. By mid-­September the price of oil had fallen 22.2 percent, and E&P stocks were down 32.0 percent. Slipping one rung to third place is the Goldman, Sachs & Co. quartet now led by John Marshall, following Maria Grant’s January promotion to deputy director of U.S. equities research. In ­July the team recommended buying call options on Amgen — a biotech­nology giant head­quartered in Thousand Oaks, California — in anticipation of the stock’s gaining on news of favorable results from a clinical study of its osteoporosis drug, Denosumab. Amgen’s share price was up 25.1 percent in mid-­September.

Return to The Best Analysts of the Year

Return to Rankings

Gift this article